MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. EV/EBITDA Ratio 2011-2026 | PRAH
Annual EV/EBITDA Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 20.8 | 15.7 | 17.8 | 20.1 | 14.9 | 13.8 | 12.9 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.8 | 12.9 | 16.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
27.4 | $ 119.97 | 0.82 % | $ 36.5 B |  USA |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 2.96 | 4.59 % | $ 96.1 K | USA |
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 22.65 | -3.78 % | $ 237 M |  China |
 |
Celcuity
CELC
|
-2.38 | $ 110.91 | 3.27 % | $ 4.38 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 28.34 | 2.79 % | $ 787 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 179.2 | 1.92 % | $ 8.88 B | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 14.0 | 1.53 % | $ 423 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-4.25 | $ 14.83 | -4.32 % | $ 1.92 B | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 650.18 | 2.3 % | $ 52.3 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 129.26 | -0.23 % | $ 20.6 B | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.15 | 2.68 % | $ 1.46 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 208.68 | 0.16 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 204.99 | 0.47 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.52 | 0.15 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
26.4 | $ 8.57 | -2.0 % | $ 537 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 9.51 | -7.67 % | $ 270 M | Israel |
 |
DexCom
DXCM
|
39.5 | $ 73.23 | 0.21 % | $ 28.6 B | USA |
 |
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
38 | $ 110.76 | 1.89 % | $ 9.14 B |  Irlanda |
 |
Renalytix AI plc
RNLX
|
-32.1 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-100 | $ 19.25 | 2.37 % | $ 1.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 281.56 | -0.53 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 77.63 | -1.53 % | $ 5.24 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
-28.8 | $ 93.91 | 0.65 % | $ 11.8 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 176.67 | 1.53 % | $ 30.4 B | USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 12.53 | 8.07 % | $ 99.4 M | Israel |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 299.09 | -1.29 % | $ 26.8 B | Schweiz |
 |
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | USA |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 5.36 | 1.23 % | $ 496 M | USA |